Halozyme Therapeutics Plummets On Q3 Losses By: Benzinga via Benzinga November 10, 2014 at 17:19 PM EST Halozyme Therapeutics, Inc. (NASDAQ: HALO) reported financial results Monday for the third quarter ended September 30, 2014. ... Read More >> Related Stocks: Halozyme Therapeutic